Can Doctors Prescribe Semaglutide for Weight Loss?

Last reviewed: June 9, 2026

Last updated: June 9, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, a GLP-1 receptor agonist originally developed for type 2 diabetes, is legally prescribed off-label by doctors across the United States for weight loss in eligible patients. The medication works by slowing stomach emptying and signaling fullness to the brain, leading to reduced hunger and calorie intake. PlexusDx partners with licensed 503A compounding pharmacies to deliver affordable, personalized semaglutide therapy at $189/mo month-to-month, or from $149/mo on the 6-month plan.

Off-Label Prescribing: Legal Framework for Weight Loss Semaglutide

Once the FDA approves a medication for any condition, physicians have the legal authority to prescribe it for other medically appropriate uses—a practice called off-label prescribing. Semaglutide received FDA approval for type 2 diabetes management in 2017, which gave doctors the foundation to prescribe it for weight loss in patients who meet clinical criteria. This off-label approach has become standard in obesity medicine, supported by clinical guidelines from major medical organizations.

Off-label prescribing is not experimental or unproven; it reflects how medicine evolves as physicians gain real-world experience with medications. Studies have consistently shown semaglutide's effectiveness for weight reduction, and many insurers now cover it for weight management in patients with a BMI of 30 or higher, or 27 with weight-related comorbidities. PlexusDx works with licensed physicians who understand semaglutide's mechanism, appropriate dosing, and patient selection criteria to ensure safe, effective treatment.

How Doctors Determine Semaglutide Eligibility for Weight Management

Physicians evaluate several factors before prescribing semaglutide for weight loss, including body mass index (BMI), medical history, current medications, and presence of weight-related conditions like hypertension or prediabetes. Candidates typically have a BMI of 30 or higher, or a BMI of 27 with at least one weight-related health condition. The doctor also screens for contraindications such as personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2.

During the initial consultation, PlexusDx-affiliated physicians review metabolic health, assess lifestyle factors, and discuss treatment goals and expectations. Some patients benefit from the Precision Peptide Genetic Test, which identifies individual variations in GLP-1 receptors, GIPR pathways, and appetite-regulation genes to optimize compound selection and dosing strategy. This personalized approach helps match each patient to the most effective therapy for their genetic and metabolic profile.

Compounded vs. Brand-Name Semaglutide: What Doctors Choose

PlexusDx provides semaglutide from licensed 503A compounding pharmacies, which prepare medications in smaller batches under strict quality and sterility standards. Compounded semaglutide is chemically identical to brand-name versions but is often more affordable and doesn't require insurance approval, making it accessible to patients nationwide. Physicians prescribe compounded formulations when they meet patient needs for affordability, flexibility, or rapid access.

The FDA regulates 503A compounding pharmacies through the Pharmacy Compounding Accreditation Board and state pharmacy boards to ensure product quality and safety. PlexusDx's compounding partners follow USP (United States Pharmacopeia) standards for strength, purity, and sterility. Your dose may need to go up as your body adapts, but your price won't—PlexusDx maintains flat monthly pricing at $189/mo month-to-month, or from $149/mo on the 6-month plan regardless of dose adjustments.

What to Expect When Your Doctor Prescribes Semaglutide for Weight Loss

Treatment begins with a low dose—typically 0.25 mg weekly—and increases gradually over 16 to 20 weeks to minimize gastrointestinal side effects and allow your body to adapt. Most patients inject semaglutide once per week using a prefilled pen or syringe, and dosing is adjusted based on tolerance and weight-loss response. Your PlexusDx physician monitors your progress through regular check-ins and may order labs to assess metabolic markers.

Common early side effects include mild nausea, constipation, or reduced appetite intensity, which often resolve within 2 to 4 weeks as your body adjusts. Staying hydrated, eating protein-rich meals, and managing carbohydrate intake help minimize digestive discomfort. PlexusDx patients receive ongoing support from licensed physicians and access to compounded semaglutide without membership fees or insurance requirements, with HSA and FSA eligibility for additional savings.

Clinical Evidence: Why Doctors Prescribe Semaglutide Off-Label

The STEP trials, conducted between 2020 and 2021, demonstrated that semaglutide 2.4 mg weekly produced an average weight loss of 10 to 17% of body weight over 68 weeks in patients without diabetes. Participants achieved significant reductions in waist circumference and improvements in blood pressure and blood sugar control. These results convinced many physicians that semaglutide represented a meaningful option for chronic weight management beyond type 2 diabetes treatment.

Follow-up research has shown that weight loss effects persist as long as patients continue treatment, and stopping semaglutide typically leads to gradual weight regain. PlexusDx physicians use this evidence to counsel patients on the realistic timeline for results (usually 4 to 12 weeks before noticeable changes) and the importance of sustained treatment for durable outcomes. Genetic testing through the Precision Peptide Genetic Test can identify which patients may respond most robustly to semaglutide based on GIPR genetic variants.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Do I need a prescription from a doctor to get semaglutide for weight loss?

Yes, semaglutide for weight loss requires a valid prescription from a licensed physician. PlexusDx connects you with qualified doctors who evaluate your health history and determine eligibility before issuing a prescription to a licensed 503A compounding pharmacy for preparation and shipment.

Is compounded semaglutide as effective as brand-name Ozempic or Wegovy?

Compounded semaglutide contains the same active pharmaceutical ingredient as brand-name versions and works through identical biological mechanisms. PlexusDx's compounding partners follow FDA-regulated USP standards for quality and sterility, ensuring pharmaceutical equivalence at a lower cost and without insurance requirements.

How much does semaglutide cost through PlexusDx?

PlexusDx offers compounded semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan with flat pricing across all dose levels. Additional options include oral semaglutide at $289/mo (or $249/mo on the 6-month plan), and both are HSA/FSA eligible with no membership fees or insurance requirements for all 50 states.

What are the most common side effects of semaglutide for weight loss?

Early side effects include nausea, constipation, reduced appetite, and occasional vomiting—most mild to moderate and typically resolving within 2 to 4 weeks. Serious side effects are rare but may include pancreatitis or gallbladder issues; your PlexusDx physician monitors for these through regular check-ins and lab work.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

Yes, the PlexusDx Precision Peptide Genetic Test ($298) identifies variations in GLP-1 receptor and GIPR genes that influence medication response, helping your doctor optimize your therapy for maximum weight loss and tolerability.

Related Reading

• Semaglutide For Weight Loss 2
• Semaglutide Tablets For Weight Loss
• Semaglutide Pills For Weight Loss
• Oral Semaglutide Weight Loss

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.